PŘEHLEDOVÉ ČLÁNKY Střevní mikrobiom ve vnitřním lékařství 28 | VNITŘNÍ LÉKAŘSTVÍ / Vnitř Lék. 2026;72(1):22-28 / www.casopisvnitrnilekarstvi.cz 21. Feng Z, Zhang Y, Chen D, et al. Causal relationship between gut microbiota and kidney diseases: a two-sample Mendelian randomization study. Front Immunol. 2023;14:1277554. [Internet]. 2023 Jan 12 [cited 2025 Dec 7]. Available from: https:// gwas.mrcieu.ac.uk/. 22. Kim MG, Cho WY, Park MS, et al. Altered gut microbiome plays an important role in AKI to CKD transition in aged mice. Front Med (Lausanne). 2023;10:1238960. [Internet]. 2023 Oct 31 [cited 2025 Dec 7]. Available from: http://www.bio-protocol.org/e1289. 23. Holle J, Reitmeir R, Potapenko O, et al. Gut microbiome alterations precede graft rejection in kidney transplantation patients. Am J Transplant. 2025;25(8):1643-1656. 24. Kim YC, Sohn KH, Kang HR. Gut microbiota dysbiosis and its impact on asthma and other lung diseases: potential therapeutic approaches. Korean J Intern Med. 2024;39(5):746. 25. Tanevska E, Leyton CE, Seamark R. The usefulness of microbiome profiling for geriatric patients with neuropsychiatric conditions: a scoping review. Transl Psychiatry. 2025;15(1):420. 26. Seo D oh, Holtzman DM. Current understanding of the Alzheimer’s disease-associated microbiome and therapeutic strategies. Exp Mol Med. 2024;56(1):86-94. 27. Eyting M, Xie M, Geldsetzer P, et al. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. 2025;641(8062):438-446. 28. Fliegerová KO, Mahayri TM, Jarošíková R, et al. Diabetes and gut microbiome. Front Microbiol. 2024;15:1451054. 29. Deng X, Zhang C, Wang P, et al. Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes. J Clin Endocrinol Metab. 2022;107(7):1888-1896. [Internet]. 2022 Jun 16 [cited 2025 Dec 7]. Available from: https://dx.doi.org/10.1210/clinem/dgac210. 30. Shaheen WA, Quraishi MN, Iqbal TH. Gut microbiome and autoimmune disorders. Clin Exp Immunol. 2022;209(2):161-174. [Internet]. 2022 Aug 19 [cited 2025 Dec 8]. Available from: https://dx.doi.org/10.1093/cei/uxac057. 31. Foretz M, Guigas B, Viollet B. Metformin: update on mechanisms of action and repurposing potential. Nat Rev Endocrinol. 2023;19(8):460-476. [Internet]. 2023 May 2 [cited 2025 Dec 7]. Available from: https://www.nature.com/articles/s41574-023-00833-4. 32. Routy B, Le Chatelier E, Daillère R, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359(6371):91-97. [Internet]. 2018 Jan 5 [cited 2025 Dec 7]. Available from: https://www.science.org/doi/10.1126/science.aan3706. 33. Kumar A, Sun R, Palm NW, et al. Identification of medication–microbiome interactions that affect gut infection. Nature. 2025;644(8076):506-515. [Internet]. 2025 Jul 16 [cited 2025 Dec 7]. Available from: https://www.nature.com/articles/s41586-025-09273-8. 34. Aasmets O, Taba N, Metspalu M, et al. A hidden confounder for microbiome studies: medications used years before sample collection. mSystems. 2025;???. [Internet]. 2025 Oct 22 [cited 2025 Dec 7]. Available from: https://journals.asm.org/doi/10.1128/msystems.00541-2. AI-dialogy: KDYŽ MEDICÍNA MLUVÍ NAPŘÍČ OBORY Spojili jsme sílu odborných dat a umělé inteligence, abychom vám přinesli podcasty, které vzdělávají, inspirují a šetří čas. AI-generované podcasty přinášejí to, co právě rezonuje v médiích i odborných kruzích – témata, která překračují hranice specializací a inspirují k novému pohledu na péči o pacienta. Rozšiřte si obzory poslechem podcastů s mezioborovým zaměřením.
RkJQdWJsaXNoZXIy NDA4Mjc=